- Home
- PFE
PFE
Pfizer Inc.
as 03-25-2025 2:33pm EST
| Founded: | 1849 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $31.92 | AVG Volume (30 days): | 54.3M |
| Analyst Decision: | Buy | Number of Analysts: | 14 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 1.41 | EPS Growth: | 284.33 |
| 52 Week Low/High: | $24.48 - $31.54 | Next Earning Date: | 04-29-2025 |
| Revenue: | $63,627,000,000 | Revenue Growth: | 6.84% |
| Revenue Growth (this year): | 0.06% | Revenue Growth (next year): | 0.13% |
Stock Insider Trading Activity of Pfizer Inc. (PFE)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| DAMICO JENNIFER B. | PFE | SVP & Controller | Feb 27 '25 | Sell | $25.93 | 2,500 | $64,825.00 | 11,850 | |
| BLAYLOCK RONALD E | PFE | Director | Feb 13 '25 | Buy | $25.65 | 19,457 | $499,072.05 | 27,707 |
Latest Pfizer Inc. News
PFE Breaking Stock News: Dive into PFE Ticker-Specific Updates for Smart Investing
Zacks
9 hours ago
5 Large Drug Stocks to Watch as Industry Recovers
Zacks
14 hours ago
Broadcom and Crown Castle in the Box have been highlighted as Zacks Bull and Bear of the Day
Insider Monkey
a day ago
Is Pfizer (PFE) The Best Affordable Stock To Buy According To Hedge Funds?
Zacks
a day ago
Pfizer Is a Dirt-Cheap High-Yield Stock, But Is It a Buy?
Zacks
a day ago
J&J to Invest $55B in United States to Boost Manufacturing, R&D
MT Newswires
a day ago
Apple, Pfizer Executives Wooed by China Leadership in Meeting
Insider Monkey
2 days ago
Is Pfizer Inc. (PFE) The Best Healthcare Dividend Stock to Invest in?
Simply Wall St.
2 days ago
With 67% ownership, Pfizer Inc. (NYSE:PFE) boasts of strong institutional backing
Compare PFE vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PFE Pfizer Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.